Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Current Opinion in Pharmacology|June 26, 2013
Targeting MET: why, where and how?Elena Ghiso, Silvia GiordanoCancer Research|December 17, 2008
MicroRNAs impair MET-mediated invasive growthCristina Migliore, Annalisa Petrelli, Elena Ghiso, et al.Cancer Research|September 16, 2010
MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitorsVirna Cepero, J Rafael Sierra, Simona Corso, et al.Molecular Cancer|May 27, 2010
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibitionSimona Corso, Elena Ghiso, Virna Cepero, et al.Neoplasia (New York, N.Y.)|November 15, 2017
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLCElena Ghiso, Cristina Migliore, Vito Ciciriello, et al.Hepatology (Baltimore, Md.)|March 11, 2011
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in miceMarta A Kowalik, Christian Saliba, Monica Pibiri, et al.Current Opinion in Molecular Therapeutics|August 4, 2009
Rilotumumab, a mAb against human hepatocyte growth factor for the treatment of cancerSilvia GiordanoJournal of Hepatology|July 11, 2014
YAP activation is an early event and a potential therapeutic target in liver cancer developmentAndrea Perra, Marta Anna Kowalik, Elena Ghiso, et al.EMBO Molecular Medicine|July 20, 2018
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signalingCristina Migliore, Elena Morando, Elena Ghiso, et al.Trends in Molecular Medicine|June 5, 2016
How Can Gastric Cancer Molecular Profiling Guide Future Therapies?Simona Corso, Silvia GiordanoPageof 16